If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcer Gdr Reg S Regulatory News (ACID)

  • There is currently no data for ACID

Disclosure on behalf of Acer EMEA Subsidiary

6 Aug 2015 12:11

RNS Number : 3381V
Acer Incorporated
06 August 2015
 



Subject: Disclosure on behalf of Acer EMEA Subsidiary

Date of events: 2015/08/06

Contents:

1. Date of occurrence of the event: 2015/08/06

2. The company name of the party for whom the endorsements/guarantees were made; its relationship with the Company; the ceiling on the endorsements /guarantees; the original amount of endorsements/guarantees; the amount of the current additional endorsements/guarantees; the amount of endorsements /guarantees as of the date of occurrence of the event; the actual loaned amount of the company who was made the endorsements/guarantees; the reason for the current additional endorsements/guarantees:

Acer Africa (Proprietary) Limited; Acer BSEC Incorporated ;

Acer Computer (ME) Ltd. ; Acer Computer (Switzerland) AG ;

Acer Computer B.V. ; Acer Computer France S.A.R.L. ;

Acer Computer GmbH ; Acer Computer Iberica, S.A. ;

Acer CIS Incorporated ; Acer Czech Republic s.r.o. ;

Acer Europe AG ; Acer Europe B. V. ; Acer European Holdings B.V. ;

Acer Hellas Limited Liability Company of Marketing and Sale Services ;

Acer Italy S.R.L. ; Acer Marketing Services LLC ;

Acer Sales International SA ; Acer Slovakia s.r.o. ;

Acer U.K. Limited ; AGP Insurance (Guernsey) Limited;

Asplex SP. ZOO ; Packard Bell B.V. ; Acer Poland SP.ZO.O ;

Acer Austria GMBH

12,749,368K; 0; 4,039,100K ;4,039,100K; 0; provide bank guarantee for EMEA subsidiary

3. Content and value of collaterals provided by the party for whom the endorsements/guarantees were made: No

4. Capital and accumulated profit/loss for whom the endorsements/guarantees were made according to its latest financial report: 2,001,238K; 14,991,712K

5. Terms/conditions and date of release of the Company's endorsement/guarantee obligations: guarantee cancel

6 .The total amount of ceiling on endorsement/guarantee: 63,746,841K

7. The total amount of endorsements/guarantees as of the date of occurrence of the event: 21,412,825K

8. The ratio of the amount of endorsements/guarantees to the Company's net worth according to the latest financial report as of the date of occurrence of the event:6.34

9. The ratio of the aggregate amount of long term investments, endorsements /guarantees, and monetary loans extended to others to the Company's net worth according to the latest financial report: 35.24

10. Any other matters that need to be specified: replace contract

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNRARVWAWRAR
Date   Source Headline
8th Nov 20199:22 amRNSUn-Audited Monthly Sales Ended Oct. 31, 2019
6th Nov 201910:58 amRNSTo announce the Company's information
9th Oct 201910:59 amRNSUn-Audited Monthly Sales Ended Sept 30, 2019
27th Sep 201910:29 amRNSTo announce the Company's information
12th Aug 201910:19 amRNSUn-Audited Monthly Sales Ended July 31, 2019
7th Aug 201911:06 amRNSAcer BOD resolutions of Aug 7, 2019
26th Jul 201910:07 amRNSTo announce the Company's information
9th Jul 201910:22 amRNSUn-Audited Monthly Sales Ended June 30, 2019
26th Jun 201910:33 amRNSTo Attend the UBS Taiwan Conference 2019
14th Jun 201911:12 amRNSResolutions of 2019 General Shareholders' Meeting
10th Jun 201910:11 amRNSUn-Audited Monthly Sales Ended May 31, 2019
24th May 201911:01 amRNS2019 Shareholders Meeting Information
13th May 20197:00 amRNSSupplemental announcement of 2016.11.10
10th May 201911:05 amRNSUn-Audited Monthly Sales Ended April 30, 2019
8th May 201910:49 amRNSAcer BOD resolutions of May 8, 2019
15th Apr 201910:10 amRNSTo announce the Company's information
11th Apr 20198:51 amRNSTo announce the Company's information
20th Mar 201911:13 amRNSAcer BOD Resolutions of Mar 20, 2019
20th Mar 201910:14 amRNSAcer BOD resolutions of Mar 20, 2019
8th Mar 201910:46 amRNSUn-Audited Monthly Sales Ended February 28 , 2019
18th Feb 20199:24 amRNSDisclosure on behalf of Acer subsidiary, AAH
14th Feb 20199:30 amRNSUn-Audited Monthly Sales Ended January 31, 2019
12th Feb 20199:52 amRNSTo announce the Company's information
11th Feb 20197:40 amRNSClarification of News Report
9th Jan 201910:22 amRNSUn-Audited Monthly Sales Ended December 31, 2018
4th Jan 20198:32 amRNSClarification of News Report
31st Dec 20187:00 amRNSAcer announcement
7th Dec 201812:32 pmRNSUn-Audited Monthly Sales Ended November 30, 2018
6th Dec 20189:25 amRNSAnnouncement of Capital Amendment Registration
15th Nov 20189:02 amRNSTo announce the Company's information
9th Nov 20188:46 amRNSUn-Audited Monthly Sales Ended Oct 31, 2018
7th Nov 201810:18 amRNSAcer Consolidated Financial Statements
7th Nov 201810:16 amRNSThe Appointment of Co-Chief Operating Officer
7th Nov 20189:21 amRNSCapital Reduction through Cancellation by RSA
7th Nov 20189:18 amRNSAnnouncement of the disposal shares of WLII
7th Nov 20189:18 amRNSAcer makes a donation to Acer Foundation
7th Nov 20189:15 amRNSAnnouncement on behalf of subsidiary, AHN
7th Nov 20189:14 amRNSAcer's 2018 Q3 consolidated results
8th Oct 201811:12 amRNSUn-Audited Monthly Sales Ended Sept. 30, 2018
10th Sep 201811:08 amRNSUn-Audited Monthly Sales Ended August 31, 2018
31st Aug 201810:47 amRNSAcer Inc. to Attend the Credit Suisse 19th ATC
31st Aug 201810:42 amRNSAttend Morgan Stanley Asia Pacific Corporate Day
21st Aug 20185:45 pmRNSSupplementary announcement dated 25th June 2016
9th Aug 20182:42 pmRNSUn-Audited Monthly Sales Ended July 31, 2018
8th Aug 201811:44 amRNSThe Spin-Off of Gadget Product Business
8th Aug 201811:41 amRNSAnnouncement on behalf of subsidiary, ABH
8th Aug 201810:59 amRNSAcer's 2018 Q2 consolidated results
7th Aug 20189:16 amRNSAnnouncement on behalf of subsidiary StarVR
27th Jul 201811:11 amRNSAnnouncement on behalf of subsidiary StarVR
9th Jul 201812:33 pmRNSUn-Audited Monthly Sales Ended June 30, 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.